Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol
Authors:
- Koichi OtaniKOKoichi Otani
- Tsuyoshi KondoTKTsuyoshi Kondo
- Akihito SuzukiASAkihito Suzuki
- Hanako FurukoriHFHanako Furukori
- Sunao KanekoSKSunao Kaneko
- Yoshimasa InoueYIYoshimasa Inoue
- 1 April 1998
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 22 (3) , 485-492
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Blood levels of reduced halopertool versus clinical efficacy and extrapyramidal side effects of haloperidolProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1997
- Coadministration of Fluvoxamine Increases SerumJournal of Clinical Psychopharmacology, 1994
- Haloperidol Disposition Is Dependent on the Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992
- Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1989
- Substantial rise in sparteine metabolic ratio during haloperidol treatment.British Journal of Clinical Pharmacology, 1989
- Determination of bromperidol in serum by automated column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- BromperidolDrugs, 1988
- Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?American Journal of Psychiatry, 1986
- Effect of anticonvulsants on plasma haloperidol and thioridazine levelsAmerican Journal of Psychiatry, 1980